Three years of specific immunotherapy may be sufficient in house dust mite respiratory allergy

Journal of Allergy and Clinical Immunology

Volumn 127, Issue 1, 2011, Pages

  Tabar, Ana I ^a   Arroabarren, Esozia ^b   Echechipía, Susana ^a   García, Blanca E ^a   Martin, Santiago ^c   Alvarez Puebla, María J ^a  

^a Universidad Pública de Navarra   (Spain)

^b HOSPITAL DONOSTIA   (Spain)

^c ALK ABELLÓ   (Denmark)

Author keywords

asthma; children; clinical efficacy; compliance; duration; house dust mite; immunotherapy relapses; quality of life; rhinitis; specific immunotherapy

Indexed keywords

HYMENOPTERA VENOM; IMMUNOGLOBULIN; IMMUNOGLOBULIN G4;

ADULT; ARTICLE; ASTHMA; CHILD; CONTROLLED STUDY; DERMATOPHAGOIDES PTERONYSSINUS; DOUBLE BLIND PROCEDURE; DRUG HYPERSENSITIVITY; FEMALE; HOUSE DUST ALLERGY; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RHINITIS; RHINOCONJUNCTIVITIS; SKIN TEST; SPECIFIC IMMUNOTHERAPY; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

EID: 78650889409     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2010.10.025     Document Type: Article

References (40)

1. L. Noon Prophylactic inoculation against hay fever Lancet 1911
2. R.N. Ross, H.S. Nelson, and I. Finegold Effectiveness of specific immunotherapy in the treatment of hymenoptera venom hypersensitivity: a meta-analysis Clin Ther 22 2000 351 358
3. M.J. Abramson, R.M. Puy, and J.M. Weiner Allergen immunotherapy for asthma Cochrane Database Syst Rev 4 2003 CD001186
4. M.A. Calderon, B. Alves, M. Jacobson, B. Hurwitz, A. Sheikh, and S. Durham Allergen injection immunotherapy for seasonal allergic rhinitis Cochrane Database Syst Rev 1 2007 CD001936
5. A. Des Roches, L. Paradis, J.L. Menardo, S. Bouges, J.P. Daurés, and J. Bousquet Immunotherapy with a standardized Dermatophagoides pteronyssinus extract, VI: specific immunotherapy prevents the onset of new sensitizations in children J Allergy Clin Immunol 99 1997 450 453
6. G.B. Pajno, G. Barberio, F. De Luca, L. Morabito, and S. Parmiani Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy: a six-year follow-up study Clin Exp Allergy 31 2001 1392 1397
7. C. Möller, S. Dreborg, H.A. Ferdousi, S. Halken, A. Høst, and L. Jacobsen Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study) J Allergy Clin Immunol 109 2002 251 256
8. S.R. Durham, S.M. Walker, E.M. Varga, M.R. Jacobson, F. O'Brien, and W. Noble Long term clinical efficacy of grass pollen immunotherapy N Engl J Med 341 1999 468 475
9. L. Jacobsen, B. Niggemann, S. Dreborg, H.A. Ferdousi, S. Halken, and A. Høst Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study Allergy 62 2007 943 948
10. P.A. Eng, M. Borer-Reinhold, I.A. Heijnen, and H.P. Gnehm Twelve-year follow-up after discontinuation of preseasonal grass pollen immunotherapy in childhood Allergy 61 2006 198 201
11. B. Brüggenjürgen, T. Reinhold, R. Brehler, E. Laake, G. Wiese, and U. Machate Cost-effectiveness of specific subcutaneous immunotherapy in patients with allergic rhinitis and allergic asthma Ann Allergy Asthma Immunol 101 2008 316 324
12. Joint Task Force on Practice Parameters American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma and Immunology Joint Council of Allergy, Asthma and Immunology Allergen immunotherapy: a practice parameter second update J Allergy Clin Immunol 120 suppl 3 2007 S25 S85
13. E. Alvarez-Cuesta, J. Bousquet, G.W. Canonica, S.R. Durham, H.J. Malling, and E. Valovirta EAACI, Immunotherapy Task Force. Standards for practical allergen-specific immunotherapy Allergy 61 suppl 82 2006 1 20
14. E. Lerch, and U.R. Müller Long-term protection after stopping venom immunotherapy: results of re-stings in 200 patients J Allergy Clin Immunol 101 1998 606 612
15. A. Des Roches, L. Paradis, J. Knani, A. Hejjaoui, H. Dhivert, and P. Chanez Immunotherapy with a standardized Dermatophagoides pteronyssinus extract, V: duration of the efficacy of immunotherapy after its cessation Allergy 51 1996 430 433
16. V. Di Rienzo, F. Marcucci, P. Puccinelli, S. Parmiani, F. Frati, and L. Sensi Long-lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: a 10-year prospective study Clin Exp Allergy 33 2003 206 210
17. S.J. Pocock Methods of randomization Clinical trials: a practical approach 1983 John Wiley & Sons
18. A.I. Tabar, S. Echechipía, B.E. García, J.M. Olaguibel, M.T. Lizaso, and B. Gómez Double-blind comparative study of cluster and conventional immunotherapy schedules with Dermatophagoides pteronyssinus J Allergy Clin Immunol 116 2005 109 118
19. International consensus report on the diagnosis and management of rhinitis Allergy 49 suppl 19 1994 1 34
20. National Institutes of Health 1995 epidemiology Global Initiative for Asthma: global strategy for asthma management and prevention (National Institutes of Health, National Heart, Lung and Blood Institute and World Health Organisation Workshop Report) 1995 National Institutes of Health Bethesda (MD) NIH publication no. 95:3659-60
21. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects Bull World Health Organ 79 2001 373 374
22. J.M. Olaguíbel, A.I. Tabar, B.E. García Figueroa, and C. Cortés Immunotherapy with standardized extract of Dermatophagoides pteronyssinus in bronchial asthma: a dose titration study Allergy 52 1997 168 178
23. J.M. Olaguíbel, A.I. Tabar, B.E. García, S. Martín, P. Rico, and B.E. García Figueroa Long-term immunotherapy with an optimal maintenance dose of a standardized Dermatophagoides pteronyssinus extract in asthmatic patients Invest Allergol Clin Immunol 9 1999 110 116
24. A.I. Tabar, M.T. Lizaso, B.E. García, B. Gómez, S. Echechipía, and M.T. Aldunate Double-blind, placebo-controlled study of Alternaria alternata immunotherapy: clinical efficacy and safety Pediatr Allergy Immunol 19 2008 67 75
25. E.O. Meltzer Evaluating rhinitis: clinical, rhinomanometric and cytologic assessments J Allergy Clin Immunol 82 1988 900 908
26. K. Aas Heterogeneity of bronchial asthma Allergy 36 1981 3 14
27. H.J. Malling Immunotherapy as an effective tool in allergy treatment Allergy 53 1998 461 472
28. E.O. Meltzer Quality of life in adults and children with allergic rhinitis J Allergy Clin Immunol 108 2001 S45 S53
29. E.F. Juniper, and G.H. Guyatt Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis Clin Exp Allergy 21 1991 77 83
30. E.F. Juniper, G.H. Guyatt, R.S. Epstein, P.J. Ferrie, R. Jaeschke, and T.K. Hiller Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials Thorax 47 1992 76 83
31. G.W. Canonica, C.E. Baena-Cagnani, J. Bousquet, P.J. Bousquet, R.F. Lockey, and H.J. Malling Recommendations for standardization of clinical trials with allergen specific immunotherapy for respiratory allergy: a statement of a World Allergy Organization (WAO) taskforce Allergy 62 2007 317 324
32. American Thoracic Society Standardization of spirometry, 1994 update Am J Respir Crit Care Med 152 1995 1107 1136
33. European Academy of Allergology and Clinical Immunology Position paper: allergen standardization and skin tests Allergy 48 suppl 14 1993 48 82
34. L. Cox, and J.R. Cohn Duration of allergen immunotherapy in respiratory allergy: when is enough, enough? Ann Allergy Asthma Immunol 98 2007 416 426
35. I. Ali, K. Goksal, B. Ozan, and D. Gulsen Long-term allergen-specific immunotherapy correlates with long-term allergen-specific immunological tolerance Adv Ther 25 2008 29 36
36. S.R. Durham, W. Emminger, A. Kapp, G. Colombo, J.G. de Monchy, and S. Rak Long-term clinical efficacy in grass pollen-induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet J Allergy Clin Immunol 125 2010 131 138
37. J. Mullol, A. Valero, I. Alobid, J. Bartra, A.M. Navarro, and T. Chivato Allergic Rhinitis and its Impact on Asthma update (ARIA 2008): the perspective from Spain J Investig Allergol Clin Immunol 18 2008 327 334
38. C.S. Hankin, L. Cox, D. Lang, A. Levin, G. Gross, and G. Eavy Allergy immunotherapy among Medicaid-enrolled children with allergic rhinitis: patterns of care, resource use, and costs J Allergy Clin Immunol 121 2008 227 232
39. G.B. Pajno, D. Vita, L. Caminiti, T. Arrigo, F. Lombardo, and C. Incorvaia Children's compliance with allergen immunotherapy according to administration routes J Allergy Clin Immunol 116 2005 1380 1381
40. L.K. James, and S.R. Durham Update on mechanisms of allergen injection immunotherapy Clin Exp Allergy 38 2008 1074 1088